• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nek2是B细胞发育和免疫反应的新型调节因子。

Nek2 is a novel regulator of B cell development and immunological response.

作者信息

Gu Zhimin, Zhou Wen, Huang Junwei, Yang Ye, Wendlandt Erik, Xu Hongwei, He Xiao, Tricot Guido, Zhan Fenghuang

机构信息

Department of Internal Medicine, University of Iowa City, Carver College of Medicine, Iowa City, IA 52242, USA.

Department of Internal Medicine, University of Iowa City, Carver College of Medicine, Iowa City, IA 52242, USA ; Institute of Cancer Research, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.

出版信息

Biomed Res Int. 2014;2014:621082. doi: 10.1155/2014/621082. Epub 2014 Nov 17.

DOI:10.1155/2014/621082
PMID:25485281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4251609/
Abstract

The serine/threonine kinase Nek2 is commonly found upregulated in a wide variety of neoplasms including diffuse large B cell lymphoma and multiple myeloma. High expression of Nek2 is implicated in the induction of chromosomal instability, promotion of cell proliferation, and drug resistance in tumor cells as well as a marker for poor clinical outcomes. Despite its well recorded involvement in chromosomal instability and neoplastic growth, little is known about the involvement of Nek2 in B cell development. Here we report the development of a transgenic mouse line with conditional expression of Nek2 in the B cell lineage and the effects it has on the development of B cells. Interestingly, we found that the overexpression of Nek2 does not induce spontaneous tumor formation within the transgenic mice up to 24 months after induction. Instead, overexpression of Nek2 in the B cell lineage affects the development of B cells by increasing the proportion of immature B cells in the bone marrow and decreasing B-1 B cells in peritoneal cavity. Furthermore, Nek2 transgenic mice develop spontaneous germinal centers and exhibit an enhanced T cell dependent immune response. Altogether, our data demonstrates a novel role for Nek2 in regulating B cell development and the immune response.

摘要

丝氨酸/苏氨酸激酶Nek2在包括弥漫性大B细胞淋巴瘤和多发性骨髓瘤在内的多种肿瘤中通常上调。Nek2的高表达与肿瘤细胞中染色体不稳定性的诱导、细胞增殖的促进、耐药性以及不良临床结果的标志物有关。尽管其在染色体不稳定性和肿瘤生长中的作用已有充分记录,但关于Nek2在B细胞发育中的作用知之甚少。在此,我们报告了一种在B细胞谱系中条件性表达Nek2的转基因小鼠品系的建立及其对B细胞发育的影响。有趣的是,我们发现Nek2的过表达在诱导后长达24个月的转基因小鼠中不会诱导自发肿瘤形成。相反,B细胞谱系中Nek2的过表达通过增加骨髓中未成熟B细胞的比例和减少腹腔中B-1 B细胞来影响B细胞的发育。此外,Nek2转基因小鼠会自发形成生发中心,并表现出增强的T细胞依赖性免疫反应。总之,我们的数据证明了Nek2在调节B细胞发育和免疫反应中的新作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/8c9fc57619be/BMRI2014-621082.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/95cd971a159e/BMRI2014-621082.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/a30a7aa83c12/BMRI2014-621082.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/ae30996c8ae8/BMRI2014-621082.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/be22afb39aba/BMRI2014-621082.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/8c9fc57619be/BMRI2014-621082.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/95cd971a159e/BMRI2014-621082.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/a30a7aa83c12/BMRI2014-621082.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/ae30996c8ae8/BMRI2014-621082.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/be22afb39aba/BMRI2014-621082.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1765/4251609/8c9fc57619be/BMRI2014-621082.005.jpg

相似文献

1
Nek2 is a novel regulator of B cell development and immunological response.Nek2是B细胞发育和免疫反应的新型调节因子。
Biomed Res Int. 2014;2014:621082. doi: 10.1155/2014/621082. Epub 2014 Nov 17.
2
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.NEK2 主要通过激活外排药物泵诱导耐药性,与骨髓瘤和其他癌症的不良预后相关。
Cancer Cell. 2013 Jan 14;23(1):48-62. doi: 10.1016/j.ccr.2012.12.001.
3
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.双功能抑制剂揭示 NEK2 是淋巴瘤中致癌途径的治疗靶点和调节剂。
Mol Cancer Ther. 2024 Mar 4;23(3):316-329. doi: 10.1158/1535-7163.MCT-23-0299.
4
Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.NIMA相关激酶2的过表达与前列腺癌的进展及不良预后相关。
BMC Urol. 2015 Aug 29;15:90. doi: 10.1186/s12894-015-0085-7.
5
Cell cycle-dependent expression of Nek2, a novel human protein kinase related to the NIMA mitotic regulator of Aspergillus nidulans.Nek2的细胞周期依赖性表达,Nek2是一种与构巢曲霉的NIMA有丝分裂调节因子相关的新型人类蛋白激酶。
Cell Growth Differ. 1994 Jun;5(6):625-35.
6
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.NEK2介导多发性骨髓瘤中醛脱氢酶1A1(ALDH1A1)依赖性耐药。
Oncotarget. 2014 Dec 15;5(23):11986-97. doi: 10.18632/oncotarget.2388.
7
Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma.Nek2作为抑制胆管癌致瘤性生长和腹膜播散的有效靶点。
Cancer Res. 2007 Oct 15;67(20):9637-42. doi: 10.1158/0008-5472.CAN-07-1489.
8
The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer.中心体激酶Nek2在人类乳腺癌中表现出蛋白质表达水平升高。
Cancer Res. 2004 Oct 15;64(20):7370-6. doi: 10.1158/0008-5472.CAN-04-0960.
9
Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.微小RNA-128甲基化导致的NEK2上调与结直肠癌的不良预后相关。
Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.
10
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.Nek2 在乳腺癌细胞中心体复制和非整倍体中的作用。
Oncogene. 2014 May 1;33(18):2375-84. doi: 10.1038/onc.2013.183. Epub 2013 May 27.

引用本文的文献

1
NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis.NEK2调节B细胞功能及实验性自身免疫性脑脊髓炎的严重程度。
J Neuroinflammation. 2025 Jun 6;22(1):152. doi: 10.1186/s12974-025-03472-w.
2
NEK2 is a potential pan-cancer biomarker and immunotherapy target.NEK2是一种潜在的泛癌生物标志物和免疫治疗靶点。
Discov Oncol. 2024 Nov 7;15(1):626. doi: 10.1007/s12672-024-01519-7.
3
Role of NEK2 in tumorigenesis and tumor progression.NEK2在肿瘤发生和肿瘤进展中的作用。

本文引用的文献

1
Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1ε.整合遗传学方法揭示Sox4在早期B细胞发育中的分子机制:RAG1/2和CK1ε的复杂作用
Blood. 2014 Jun 26;123(26):4064-76. doi: 10.1182/blood-2013-12-543801. Epub 2014 Apr 30.
2
Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis.研究Nek2作为非小细胞肺癌预后更好的增殖标志物。
Tumour Biol. 2014 Jul;35(7):7155-62. doi: 10.1007/s13277-014-1935-8. Epub 2014 Apr 25.
3
Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1.
Trends Mol Med. 2025 Jan;31(1):79-93. doi: 10.1016/j.molmed.2024.07.013. Epub 2024 Aug 24.
4
Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma.NEK 家族在透明细胞肾细胞癌中的预后价值和免疫浸润。
Medicine (Baltimore). 2024 Jul 19;103(29):e38961. doi: 10.1097/MD.0000000000038961.
5
Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett's Esophagus.NEK激酶家族成员在食管腺癌和巴雷特食管中的差异表达
Cancers (Basel). 2023 Sep 30;15(19):4821. doi: 10.3390/cancers15194821.
6
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.双功能抑制剂揭示 NEK2 是淋巴瘤中致癌途径的治疗靶点和调节剂。
Mol Cancer Ther. 2024 Mar 4;23(3):316-329. doi: 10.1158/1535-7163.MCT-23-0299.
7
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.高表达的 NEK2 在髓系祖细胞中抑制多发性骨髓瘤中的 T 细胞免疫。
Cell Rep Med. 2023 Oct 17;4(10):101214. doi: 10.1016/j.xcrm.2023.101214. Epub 2023 Oct 3.
8
Metabolic Biomarkers in B-Cell Lymphomas for Early Diagnosis and Prediction, as Well as Their Influence on Prognosis and Treatment.B细胞淋巴瘤中用于早期诊断和预测的代谢生物标志物及其对预后和治疗的影响
Diagnostics (Basel). 2022 Feb 3;12(2):394. doi: 10.3390/diagnostics12020394.
9
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1.NEK2 抑制通过靶向 PD-L1 触发抗胰腺癌免疫。
Nat Commun. 2021 Jul 27;12(1):4536. doi: 10.1038/s41467-021-24769-3.
10
NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance Phosphorylation in Diffuse Large B-Cell Lymphoma.NEK2通过调节弥漫性大B细胞淋巴瘤中PKM2的丰度和磷酸化促进细胞增殖和糖酵解。
Front Oncol. 2021 Jun 8;11:677763. doi: 10.3389/fonc.2021.677763. eCollection 2021.
Nek2在有丝分裂中心体处使β-连环蛋白磷酸化并使其稳定,该过程发生在Plk1下游。
Mol Biol Cell. 2014 Apr;25(7):977-91. doi: 10.1091/mbc.E13-06-0349. Epub 2014 Feb 5.
4
The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival.中心体激酶 NEK2 是一种新型的剪接因子激酶,参与细胞存活。
Nucleic Acids Res. 2014 Mar;42(5):3218-27. doi: 10.1093/nar/gkt1307. Epub 2013 Dec 24.
5
Upregulation of NEK2 is associated with drug resistance in ovarian cancer.NEK2 的上调与卵巢癌的耐药性有关。
Oncol Rep. 2014 Feb;31(2):745-54. doi: 10.3892/or.2013.2910. Epub 2013 Dec 9.
6
RARα2 expression confers myeloma stem cell features.RARα2 表达赋予骨髓瘤干细胞特征。
Blood. 2013 Aug 22;122(8):1437-47. doi: 10.1182/blood-2013-02-482919. Epub 2013 Jul 11.
7
Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model.Cdk4 和 Nek2 在 Her2+ 乳腺癌模型中引发双核和中心体扩增。
PLoS One. 2013 Jun 11;8(6):e65971. doi: 10.1371/journal.pone.0065971. Print 2013.
8
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.Nek2 在乳腺癌细胞中心体复制和非整倍体中的作用。
Oncogene. 2014 May 1;33(18):2375-84. doi: 10.1038/onc.2013.183. Epub 2013 May 27.
9
Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancer cells.Nek2 靶向 ASO 或 siRNA 预处理增强三阴性乳腺癌细胞对抗癌药物的敏感性。
Int J Oncol. 2013 Mar;42(3):839-47. doi: 10.3892/ijo.2013.1788. Epub 2013 Jan 22.
10
NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.NEK2 主要通过激活外排药物泵诱导耐药性,与骨髓瘤和其他癌症的不良预后相关。
Cancer Cell. 2013 Jan 14;23(1):48-62. doi: 10.1016/j.ccr.2012.12.001.